title: Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome.
abstract: Endothelial function impairment may constitute a link between nephrotic syndrome and atherosclerosis. We assessed changes in plasma thrombomodulin, von Willebrand factor and plasminogen activator inhibitor-1 at different stages of idiopathic nephrotic syndrome in children and correlated them with clinical and biochemical parameters. The study group included 132 nephrotic children (aged 2-18 years) divided into four groups, i.e. in acute phase of the disease with proteinuria, during steroid-induced remission, steroid-free remission, and in long-term, steroid-free remission. Forty-one healthy children served as controls. Plasma thrombomodulin, plasminogen activator inhibitor-1 and von Willebrand factor activity were increased in children with early nephrotic relapse. They systematically decreased in later stages of the disease but the increase in von Willebrand factor persisted in drug-free remission. These disturbances were dependent on the degree of proteinuria and serum albumin concentration. The study revealed that nephrotic children show markers of endothelial dysfunction that are dependent on the disease activity. This leads to the hypothesis that children with severe clinical course of nephrotic syndrome may be at high risk of accelerated atherogenesis.
authors.affiliation: Department of Nephrology and Dialysis, Polish Mother's Memorial Hospital Research Institute, Łódź, Poland. mtkaczyk@uni.lodz.pl
authors.forename: Marcin
authors.initials: M
authors.lastname: Tkaczyk
authors.forename: Aneta
authors.initials: A
authors.lastname: Czupryniak
authors.forename: Danuta
authors.initials: D
authors.lastname: Owczarek
authors.forename: Jolanta
authors.initials: J
authors.lastname: Lukamowicz
authors.forename: Michał
authors.initials: M
authors.lastname: Nowicki
mesh_terms: D000293:Adolescent; D050197:Atherosclerosis / Q000209:etiology; D015415:Biomarkers / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D004730:Endothelium, Vascular / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D008954:Models, Biological; D009404:Nephrotic Syndrome / Q000175:diagnosis*; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D018180:Thrombomodulin / Q000378:metabolism; D016896:Treatment Outcome; D014841:von Willebrand Factor / Q000378:metabolism
chemical_list: D015415:Biomarkers; D017395:Plasminogen Activator Inhibitor 1; D018180:Thrombomodulin; D014841:von Willebrand Factor